Related references
Note: Only part of the references are listed.Prognostication of Soft Tissue Sarcomas Based on Chromosome 17q Gene and Protein Status: Evaluation of TOP2A, HER-2/neu, and Survivin
Isabela Werneck da Cunha et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance
Esra Kaplan et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
The Structure of DNA-Bound Human Topoisomerase II Alpha: Conformational Mechanisms for Coordinating Inter-Subunit Interactions with DNA Cleavage
Timothy J. Wendorff et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy
George Fountzilas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization
Atocha Romero et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to Liposarcomagenesis
Ryan M. Gobble et al.
CANCER RESEARCH (2011)
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
Aimee M. Crago et al.
CURRENT OPINION IN ONCOLOGY (2011)
Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
Aliz Nikolenyi et al.
ONCOLOGY (2011)
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer
Gottfried E. Konecny et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction
Jan C. Brase et al.
CLINICAL CANCER RESEARCH (2010)
Controversies and challenges in the current management of nasopharyngeal cancer
Ivan Weng-Keong Tham et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer
Christian Schindlbeck et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance
Nathalie Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
Joseph E. Deweese et al.
NUCLEIC ACIDS RESEARCH (2009)
NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors
Takeshi Onda et al.
CANCER LETTERS (2008)
Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy - A longitudinal study
Fu-Min Fang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
NK314, a topoisomerase II inhibitor that specifically targets the α isoform
Eriko Toyoda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
HER-2 and topoisomerase II as predictors of response to chemotherapy
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma - Comparisons of four radiotherapy techniques
Fu-Min Fang et al.
CANCER (2007)
Topoisomerase IIα gene amplification in gastric carcinomas:: correlation with the HER2 gene.: An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study
Sammy Yasmin Kanta et al.
HUMAN PATHOLOGY (2006)
Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma
Srikumar Sengupta et al.
CANCER RESEARCH (2006)
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
J Wee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples
RE Mueller et al.
GENES CHROMOSOMES & CANCER (2004)
Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma - A prospective study on disease control and preservation of salivary function
DLW Kwong et al.
CANCER (2004)
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
JC Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
